176 related articles for article (PubMed ID: 38214542)
21. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
[TBL] [Abstract][Full Text] [Related]
22. Zika Virus Infection, Reproductive Organ Targeting, and Semen Transmission in the Male Olive Baboon.
Peregrine J; Gurung S; Lindgren MC; Husain S; Zavy MT; Myers DA; Papin JF
J Virol; 2019 Dec; 94(1):. PubMed ID: 31597777
[TBL] [Abstract][Full Text] [Related]
23. Replication-Deficient Zika Vector-Based Vaccine Provides Maternal and Fetal Protection in Mouse Model.
Garcia G; Chakravarty N; Abu AE; Jeyachandran AV; Takano KA; Brown R; Morizono K; Arumugaswami V
Microbiol Spectr; 2022 Oct; 10(5):e0113722. PubMed ID: 36169338
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic Effect of Zika Virus in Neuroendocrine Pancreatic Tumors: New Perspectives for Therapeutic Approaches.
Cocco MM; Carcione C; Miceli V; Tinnirello R; Chinnici CM; Carbone C; Zito G; Conaldi PG; Iannolo G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139100
[TBL] [Abstract][Full Text] [Related]
25. Clinically Relevant Cytotoxic Immune Cell Signatures and Clonal Expansion of T-Cell Receptors in High-Risk
Wei JS; Kuznetsov IB; Zhang S; Song YK; Asgharzadeh S; Sindiri S; Wen X; Patidar R; Najaraj S; Walton A; Auvil JMG; Gerhard DS; Yuksel A; Catchpoole D; Hewitt SM; Sondel PM; Seeger R; Maris JM; Khan J
Clin Cancer Res; 2018 Nov; 24(22):5673-5684. PubMed ID: 29784674
[No Abstract] [Full Text] [Related]
26. The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner.
Mazar J; Gordon C; Naga V; Westmoreland TJ
Anticancer Agents Med Chem; 2020; 20(13):1613-1625. PubMed ID: 32329693
[TBL] [Abstract][Full Text] [Related]
27. Genetic Diversity of Collaborative Cross Mice Controls Viral Replication, Clinical Severity, and Brain Pathology Induced by Zika Virus Infection, Independently of
Manet C; Simon-Lorière E; Jouvion G; Hardy D; Prot M; Conquet L; Flamand M; Panthier JJ; Sakuntabhai A; Montagutelli X
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694939
[TBL] [Abstract][Full Text] [Related]
28. Metronomic topotecan impedes tumor growth of MYCN-amplified neuroblastoma cells in vitro and in vivo by therapy induced senescence.
Taschner-Mandl S; Schwarz M; Blaha J; Kauer M; Kromp F; Frank N; Rifatbegovic F; Weiss T; Ladenstein R; Hohenegger M; Ambros IM; Ambros PF
Oncotarget; 2016 Jan; 7(3):3571-86. PubMed ID: 26657295
[TBL] [Abstract][Full Text] [Related]
29. Anti-cancer effect of oncolytic adenovirus-armed shRNA targeting MYCN gene on doxorubicin-resistant neuroblastoma cells.
Li Y; Zhuo B; Yin Y; Han T; Li S; Li Z; Wang J
Biochem Biophys Res Commun; 2017 Sep; 491(1):134-139. PubMed ID: 28711493
[TBL] [Abstract][Full Text] [Related]
30. MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma.
Lau DT; Flemming CL; Gherardi S; Perini G; Oberthuer A; Fischer M; Juraeva D; Brors B; Xue C; Norris MD; Marshall GM; Haber M; Fletcher JI; Ashton LJ
Oncotarget; 2015 Jun; 6(17):15510-23. PubMed ID: 25860940
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal Antibodies against Zika Virus NS1 Protein Confer Protection via Fc
Yu L; Liu X; Ye X; Su W; Zhang X; Deng W; Luo J; Xiang M; Guo W; Zhang S; Xu W; Yan Q; Wang Q; Cui Y; Wu C; Guo W; Niu X; Zhang F; Lei C; Qu L; Chen L; Feng L
mBio; 2021 Feb; 12(1):. PubMed ID: 33563822
[TBL] [Abstract][Full Text] [Related]
32. Zika M Oligopeptide ZAMP Confers Cell Death-Promoting Capability to a Soluble Tumor-Associated Antigen through Caspase-3/7 Activation.
Vanwalscappel B; Haddad JG; Almokdad R; Decotter J; Gadea G; Desprès P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33339164
[TBL] [Abstract][Full Text] [Related]
33. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas.
Westermann F; Muth D; Benner A; Bauer T; Henrich KO; Oberthuer A; Brors B; Beissbarth T; Vandesompele J; Pattyn F; Hero B; König R; Fischer M; Schwab M
Genome Biol; 2008 Oct; 9(10):R150. PubMed ID: 18851746
[TBL] [Abstract][Full Text] [Related]
34. Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in Dogs with Advanced-Stage Brain Tumors.
Kaid C; Madi RADS; Astray R; Goulart E; Caires-Junior LC; Mitsugi TG; Moreno ACR; Castro-Amarante MF; Pereira LR; Porchia BFMM; de Andrade TO; Landini V; Sanches DS; Pires CG; Tanioka RKO; Pereira MCL; Barbosa IN; Massoco CO; Ferreira LCS; Okamoto OK; Zatz M
Mol Ther; 2020 May; 28(5):1276-1286. PubMed ID: 32220305
[TBL] [Abstract][Full Text] [Related]
35. p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.
Yogev O; Barker K; Sikka A; Almeida GS; Hallsworth A; Smith LM; Jamin Y; Ruddle R; Koers A; Webber HT; Raynaud FI; Popov S; Jones C; Petrie K; Robinson SP; Keun HC; Chesler L
Cancer Res; 2016 May; 76(10):3025-35. PubMed ID: 27197232
[TBL] [Abstract][Full Text] [Related]
36. Different Degrees of 5'-to-3' DAR Interactions Modulate Zika Virus Genome Cyclization and Host-Specific Replication.
Li XD; Deng CL; Yuan ZM; Ye HQ; Zhang B
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826997
[TBL] [Abstract][Full Text] [Related]
37. Differential Susceptibility of Ex Vivo Primary Glioblastoma Tumors to Oncolytic Effect of Modified Zika Virus.
Garcia G; Chakravarty N; Paiola S; Urena E; Gyani P; Tse C; French SW; Danielpour M; Breunig JJ; Nathanson DA; Arumugaswami V
Cells; 2023 Sep; 12(19):. PubMed ID: 37830597
[TBL] [Abstract][Full Text] [Related]
38. Oncolytic viral therapy for neuroblastoma cells with Sindbis virus AR339 strain.
Takenouchi A; Saito K; Saito E; Saito T; Hishiki T; Matsunaga T; Isegawa N; Yoshida H; Ohnuma N; Shirasawa H
Pediatr Surg Int; 2015 Dec; 31(12):1151-9. PubMed ID: 26298056
[TBL] [Abstract][Full Text] [Related]
39. FOXR2 Stabilizes MYCN Protein and Identifies Non-
Schmitt-Hoffner F; van Rijn S; Toprak UH; Mauermann M; Rosemann F; Heit-Mondrzyk A; Hübner JM; Camgöz A; Hartlieb S; Pfister SM; Henrich KO; Westermann F; Kool M
J Clin Oncol; 2021 Oct; 39(29):3217-3228. PubMed ID: 34110923
[TBL] [Abstract][Full Text] [Related]
40. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma.
Schramm A; Köster J; Marschall T; Martin M; Schwermer M; Fielitz K; Büchel G; Barann M; Esser D; Rosenstiel P; Rahmann S; Eggert A; Schulte JH
Int J Cancer; 2013 Feb; 132(3):E106-15. PubMed ID: 22907398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
